• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

深入探讨澳大利亚高性能和职业体育领域 COVID-19 的检测和管理。

A deep dive into testing and management of COVID-19 for Australian high performance and professional sport.

机构信息

Australian Institute of Sport, Canberra, ACT, Australia; The University of Canberra Research Institute for Sport and Exercise, University of Canberra, ACT, Australia.

Australian Institute of Sport, Canberra, ACT, Australia.

出版信息

J Sci Med Sport. 2020 Jul;23(7):664-669. doi: 10.1016/j.jsams.2020.05.005. Epub 2020 May 7.

DOI:10.1016/j.jsams.2020.05.005
PMID:32418804
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7204746/
Abstract

The purpose of testing for any communicable disease is to support clinicians in the diagnosis and management of individual patients and to describe transmission dynamics. The novel coronavirus is formally named SARS-CoV-2 and the clinical disease state resulting from an infection is known as COVID-19. Control of the COVID-19 pandemic requires clinicians, epidemiologists, and public health officials to utilise the most comprehensive, accurate and timely information available to manage the rapidly evolving COVID-19 environment. High performance sport is a unique context that may look towards comprehensive testing as a means of risk mitigation. Characteristics of the common testing options are discussed including the circumstances where additional testing may be of benefit and considerations for the associated risks. Finally, a review of the available technology that could be considered for use by medical staff at the point of care (PoC) in a high-performance sporting context is included.

摘要

检测任何传染病的目的是为了帮助临床医生对个体患者进行诊断和管理,并描述传播动态。新型冠状病毒被正式命名为 SARS-CoV-2,由感染引起的临床疾病状态称为 COVID-19。控制 COVID-19 大流行需要临床医生、流行病学家和公共卫生官员利用最全面、准确和及时的信息来管理快速变化的 COVID-19 环境。高水平运动是一个独特的环境,可能会将全面检测作为降低风险的一种手段。讨论了常见检测选项的特点,包括在哪些情况下额外的检测可能会带来好处,以及对相关风险的考虑。最后,还回顾了在高水平运动环境中,医护人员在护理点(PoC)可以考虑使用的现有技术。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4baa/7204746/e5ea36c0c124/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4baa/7204746/3f2e3fbfad2d/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4baa/7204746/e5ea36c0c124/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4baa/7204746/3f2e3fbfad2d/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4baa/7204746/e5ea36c0c124/gr2_lrg.jpg

相似文献

1
A deep dive into testing and management of COVID-19 for Australian high performance and professional sport.深入探讨澳大利亚高性能和职业体育领域 COVID-19 的检测和管理。
J Sci Med Sport. 2020 Jul;23(7):664-669. doi: 10.1016/j.jsams.2020.05.005. Epub 2020 May 7.
2
Selecting a SARS-CoV-2/COVID Molecular Testing Method for Your Laboratory.为您的实验室选择一种SARS-CoV-2/新冠病毒分子检测方法。
J Appl Lab Med. 2020 Jul 1;5(4):837-840. doi: 10.1093/jalm/jfaa076.
3
COVID-19 surveillance for all newborns at the NICU; conditio sine qua non?对新生儿重症监护病房(NICU)的所有新生儿进行2019冠状病毒病监测;必不可少的条件?
Eur J Pediatr. 2020 Dec;179(12):1945-1947. doi: 10.1007/s00431-020-03773-7.
4
Diagnosing COVID-19: The Disease and Tools for Detection.诊断 COVID-19:疾病与检测工具。
ACS Nano. 2020 Apr 28;14(4):3822-3835. doi: 10.1021/acsnano.0c02624. Epub 2020 Mar 30.
5
[SARS-CoV-2 and Microbiological Diagnostic Dynamics in COVID-19 Pandemic].[严重急性呼吸综合征冠状病毒2与2019冠状病毒病大流行中的微生物诊断动态]
Mikrobiyol Bul. 2020 Jul;54(3):497-509. doi: 10.5578/mb.69839.
6
Serological tests for COVID-19.新型冠状病毒肺炎的血清学检测
Med J Aust. 2020 Nov;213(9):397-399.e1. doi: 10.5694/mja2.50766. Epub 2020 Sep 6.
7
From Mitigation to Containment of the COVID-19 Pandemic: Putting the SARS-CoV-2 Genie Back in the Bottle.从缓解到遏制新冠疫情:将新冠病毒这一精灵重新装入瓶中
JAMA. 2020 May 19;323(19):1889-1890. doi: 10.1001/jama.2020.6572.
8
Laboratory diagnosis for Covid-19: A mini-review.Covid-19 的实验室诊断:一篇迷你综述。
Rev Soc Bras Med Trop. 2020;53:e20200451. doi: 10.1590/0037-8682-0451-2020. Epub 2020 Aug 26.
9
The Promise and Peril of Antibody Testing for COVID-19.新冠病毒抗体检测的前景与风险
JAMA. 2020 May 19;323(19):1881-1883. doi: 10.1001/jama.2020.6170.
10
Editorial: Diagnostic Testing for SARS-Coronavirus-2 in the Nursing Facility: Recommendations of a Delphi Panel of Long-Term Care Clinicians.社论:护理院中 SARS-CoV-2 的诊断检测:长期护理临床医生德尔菲小组的建议。
J Nutr Health Aging. 2020;24(6):538-443. doi: 10.1007/s12603-020-1401-9.

引用本文的文献

1
Choice of SARS-CoV-2 diagnostic test: challenges and key considerations for the future.SARS-CoV-2 诊断检测方法的选择:未来的挑战和关键考虑因素。
Crit Rev Clin Lab Sci. 2022 Nov;59(7):445-459. doi: 10.1080/10408363.2022.2045250. Epub 2022 Mar 15.
2
Diagnostic Efficiency of Three Fully Automated Serology Assays and Their Correlation with a Novel Surrogate Virus Neutralization Test in Symptomatic and Asymptomatic SARS-COV-2 Individuals.三种全自动血清学检测方法在有症状和无症状的新冠病毒感染者中的诊断效率及其与新型替代病毒中和试验的相关性
Microorganisms. 2021 Jan 25;9(2):245. doi: 10.3390/microorganisms9020245.

本文引用的文献

1
Estimating the false-negative test probability of SARS-CoV-2 by RT-PCR.估算 RT-PCR 检测 SARS-CoV-2 的假阴性率。
Euro Surveill. 2020 Dec;25(50). doi: 10.2807/1560-7917.ES.2020.25.50.2000568.
2
Nanopore Targeted Sequencing for the Accurate and Comprehensive Detection of SARS-CoV-2 and Other Respiratory Viruses.纳米孔靶向测序技术用于 SARS-CoV-2 及其他呼吸道病毒的准确、全面检测。
Small. 2020 Aug;16(32):e2002169. doi: 10.1002/smll.202002169. Epub 2020 Jun 24.
3
Serology characteristics of SARS-CoV-2 infection after exposure and post-symptom onset.
感染 SARS-CoV-2 后的血清学特征:暴露后及症状出现后。
Eur Respir J. 2020 Aug 27;56(2). doi: 10.1183/13993003.00763-2020. Print 2020 Aug.
4
COVID-19: the case for health-care worker screening to prevent hospital transmission.新型冠状病毒肺炎:医护人员筛查以预防医院内传播的理由
Lancet. 2020 May 2;395(10234):1418-1420. doi: 10.1016/S0140-6736(20)30917-X. Epub 2020 Apr 16.
5
Saliva is a reliable tool to detect SARS-CoV-2.唾液是检测 SARS-CoV-2 的可靠工具。
J Infect. 2020 Jul;81(1):e45-e50. doi: 10.1016/j.jinf.2020.04.005. Epub 2020 Apr 14.
6
Temporal dynamics in viral shedding and transmissibility of COVID-19.新冠病毒脱落和传播的时间动态。
Nat Med. 2020 May;26(5):672-675. doi: 10.1038/s41591-020-0869-5. Epub 2020 Apr 15.
7
Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens.SARS-CoV-2 与其他呼吸道病原体的合并感染率。
JAMA. 2020 May 26;323(20):2085-2086. doi: 10.1001/jama.2020.6266.
8
Delivery of infection from asymptomatic carriers of COVID-19 in a familial cluster.COVID-19 无症状感染者在家庭聚集性病例中的传播。
Int J Infect Dis. 2020 May;94:133-138. doi: 10.1016/j.ijid.2020.03.042. Epub 2020 Apr 2.
9
Laboratory Diagnosis of COVID-19: Current Issues and Challenges.新型冠状病毒肺炎的实验室诊断:当前的问题和挑战。
J Clin Microbiol. 2020 May 26;58(6). doi: 10.1128/JCM.00512-20.
10
Chest CT Features of COVID-19 in Rome, Italy.意大利罗马地区 COVID-19 的胸部 CT 特征。
Radiology. 2020 Aug;296(2):E79-E85. doi: 10.1148/radiol.2020201237. Epub 2020 Apr 3.